CRISPR/Cas9 from bench to bedside: what clinicians need to know before application?

Pressure ulcers: what clinicians need to know.

William T Wake, MD, fAAfP, is a Physician in the Department of Family Medicine and Department of Continuing Care at the Baldwin Park Medical Center in CA. E-mail: [email protected]. Introduction Pressure ulcer treatment is one of many aspects of patient care in which nursing care interfaces directly with clinician-provided medical services. Traditionally, the treatment of pressure ulcers ha...

Middle East respiratory syndrome: what clinicians need to know.

A severe viral illness caused by a newly discovered coronavirus was first reported in the Middle East in 2012. The virus has since been named the Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV cases have been reported in several countries around the world in travelers from the Middle East. The illness has a high mortality rate. Limited human-to-human transmission has occurred...

Impactful clinical trials of 2012: what clinicians need to know.

The results of clinical trials serve to inform cardiovascular (CV) practice. In 2012, a number of clinical trials were reported that have an immediate effect on patient management. We highlight the results of key trials in several areas: interventional cardiology, acute coronary syndromes (ACS), and pharmacologic therapy. The FREEDOM trial, which demonstrated a significant benefit on hard outco...

Drug interactions with warfarin: what clinicians need to know.

What clinicians need to know before assessing risk in sexual offenders †

†This is the first of two articles in Advances by Rajan Darjee and Katharine Russell that discuss the clinical assessment and management of risk in sexual offenders. The next will appear in the January 2013 issue. Rarely a week goes by without a media story about the dangers posed by sexual offenders; no other group is subject to the same degree of societal fear, hatred and disgust, and these d...